Kits Eyecare (KITS) Stock Price, News & Analysis

Company Overview

KITS (TSX: KITS) is one of the world's fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.

Key Stats

• Today's Range: C$12.78 to C$13.32
• 50-Day Range: C$10.84 to C$15.81
• 52-Week Range: C$10.61 to C$22.56
• Volume: 212,085 shs
• Average Volume: 124,104 shs
• Market Capitalization: C$449.41 million
• P/E Ratio: 132.20
• Dividend Yield: N/A
• Price Target: C$20.69
• Consensus Rating: Buy

Kits Eyecare Stock Analysis - MarketRank™

Kits Eyecare scored higher than 59% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Buy

Consensus Rating

Kits Eyecare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 4 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

Kits Eyecare has a consensus price target of C$20.69, representing about 56.5% upside from its current price of C$13.22.

Amount of Analyst Coverage

Kits Eyecare has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Kits Eyecare is 132.20, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.92.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for KITS.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Kits Eyecare does not currently pay a dividend.

Dividend Growth

Kits Eyecare does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

2 people have searched for KITS on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 3.8 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

2 insiders have purchased shares of Kits Eyecare in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net C$411,910.00 in company stock, which represents 0.0917% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Kits Eyecare insiders have bought more of their company's stock than they have sold. Specifically, they have bought C$411,910.00 in company stock and sold C$0.00 in company stock.

Percentage Held by Institutions

15.17% of the stock of Kits Eyecare is held by institutions.

Company Calendar

• Last Earnings: 5/06/2026
• Today: 5/30/2026
• AGM 2026: 6/03/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: TSE:KITS
• CIK: N/A
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Kits Eyecare: C$20.69
• High Price Target: C$23.00
• Low Price Target: C$16.75
• Potential Upside/Downside: +56.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 132.20
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: C$213.33 million
• Price / Sales: 2.11
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 33,995,000
• Free Float: N/A
• Market Cap: C$449.41 million
• Optionable: N/A
• Beta: 0.46